Cargando…
Nrf2 regulates cell motility through RhoA–ROCK1 signalling in non-small-cell lung cancer cells
Nuclear factor-erythroid 2-related factor 2 (Nrf2) is a key transcriptional regulator of several antioxidant and anti-inflammatory enzymes. It binds to its endogenous inhibitor Kelch-like ECH-associated protein 1 (Keap1) in the cytoplasm under normal conditions. Various endogenous or environmental o...
Autores principales: | Ko, Eunsun, Kim, Dasom, Min, Dong Wha, Kwon, Seung-Hae, Lee, Ji-Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806835/ https://www.ncbi.nlm.nih.gov/pubmed/33441941 http://dx.doi.org/10.1038/s41598-021-81021-0 |
Ejemplares similares
-
The RhoA-ROCK pathway in the regulation of T and B cell responses
por: Ricker, Edd, et al.
Publicado: (2016) -
α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling
por: Yao, Jialin, et al.
Publicado: (2016) -
NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction
por: Zhang, Chao, et al.
Publicado: (2016) -
Hypoxia-induced galectin-3 enhances RhoA function to activate the motility of tumor cells in non-small cell lung cancer
por: Kataoka, Yoko, et al.
Publicado: (2019) -
FKBP51 regulates cell motility and invasion via RhoA signaling
por: Takaoka, Miho, et al.
Publicado: (2017)